Stocks · Health care · Pharmaceutical Preparations

Greenwich LifeSciences, Inc.

GLSI Clue Score23
United States Fiscal year ends December CIK 0001799788

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Snehal Patel
29 Jul 2026
CEO and CFO
Buy
700
$13.10
$9.17K
Snehal Patel
28 Jul 2026
CEO and CFO
Buy
1,500
$13.59
$20.39K
Snehal Patel
27 Jul 2026
CEO and CFO
Buy
1,500
$13.62
$20.43K
Snehal Patel
24 Jul 2026
CEO and CFO
Buy
1,100
$12.88
$14.17K
Snehal Patel
23 Jul 2026
CEO and CFO
Buy
2,500
$13.14
$32.85K
Snehal Patel
13 Jan 2026
CEO and CFO
Buy
1,800
$29.83
$53.69K
Snehal Patel
12 Jan 2026
CEO and CFO
Buy
2,900
$27.54
$79.87K
Snehal Patel
31 Dec 2025
CEO and CFO
Buy
4,300
$21.36
$91.85K
Snehal Patel
30 Dec 2025
CEO and CFO
Buy
2,900
$21.73
$63.02K
Snehal Patel
18 Dec 2025
CEO and CFO
Buy
4,100
$12.62
$51.74K
Snehal Patel
25 Nov 2025
CEO and CFO
Buy
4,600
$8.37
$38.50K
Snehal Patel
7 Nov 2025
CEO and CFO
Buy
10,600
$8.43
$89.36K
Snehal Patel
31 Oct 2025
CEO and CFO
Buy
2,300
$9.26
$21.30K
Snehal Patel
25 Apr 2025
CEO and CFO
Buy
3,600
$9.88
$35.57K
Snehal Patel
17 Apr 2025
CEO and CFO
Buy
5,400
$8.98
$48.49K
Snehal Patel
7 Apr 2025
CEO and CFO
Buy
3,600
$9.10
$32.76K
Snehal Patel
4 Apr 2025
CEO and CFO
Buy
5,500
$8.73
$48.02K
Snehal Patel
10 Jan 2025
CEO and CFO
Buy
2,500
$12.51
$31.28K
Snehal Patel
7 Jan 2025
CEO and CFO
Buy
1,800
$13.75
$24.75K
Snehal Patel
6 Jan 2025
CEO and CFO
Buy
1,100
$13.31
$14.64K
Snehal Patel
3 Jan 2025
CEO and CFO
Buy
3,400
$12.95
$44.03K
Snehal Patel
2 Jan 2025
CEO and CFO
Buy
2,000
$11.97
$23.94K
Snehal Patel
31 Dec 2024
CEO and CFO
Buy
2,400
$11.36
$27.26K
Snehal Patel
30 Dec 2024
CEO and CFO
Buy
3,200
$11.12
$35.58K
Jaye Thompson
21 Nov 2024
VP Clinical Reg Affairs
Buy
1,000
$12.91
$12.91K
Snehal Patel
26 Sep 2024
CEO and CFO
Buy
1,500
$14.63
$21.95K
Jaye Thompson
12 Aug 2024
VP Clinical Reg Affairs
Buy
800
$13.85
$11.08K
Snehal Patel
6 Aug 2024
CEO and CFO
Buy
2,000
$13.81
$27.62K
Snehal Patel
5 Aug 2024
CEO and CFO
Buy
5,500
$13.18
$72.49K
Jaye Thompson
2 Aug 2024
VP Clinical Reg Affairs
Buy
1,000
$15.15
$15.15K
Snehal Patel
23 Jul 2024
CEO and CFO
Buy
1,500
$15.89
$23.84K
Jaye Thompson
18 Jul 2024
VP Clinical Reg Affairs
Buy
1,000
$16.00
$16.00K
Snehal Patel
13 Jun 2024
CEO and CFO
Buy
174,825
$14.30
$2.50M
Snehal Patel
1 Apr 2024
CEO and CFO
Buy
3,000
$19.08
$57.24K
Snehal Patel
22 Mar 2024
CEO and CFO
Buy
2,500
$19.98
$49.95K
Snehal Patel
20 Mar 2024
CEO and CFO
Buy
1,500
$17.68
$26.52K
Snehal Patel
5 Mar 2024
CEO and CFO
Buy
30,500
$12.49
$380.95K
Snehal Patel
4 Mar 2024
CEO and CFO
Buy
4,100
$13.03
$53.42K
Snehal Patel
16 Feb 2024
CEO and CFO
Buy
10,800
$11.16
$120.53K
Snehal Patel
15 Feb 2024
CEO and CFO
Buy
12,700
$11.07
$140.59K
Snehal Patel
10 Nov 2023
CEO and CFO
Buy
5,000
$10.17
$50.84K
Snehal Patel
3 Nov 2023
CEO and CFO
Buy
3,500
$9.11
$31.89K
Jaye Thompson
27 Oct 2023
VP Clinical Reg Affairs
Buy
500
$8.57
$4.29K
Snehal Patel
26 Oct 2023
CEO and CFO
Buy
2,500
$7.97
$19.93K
Snehal Patel
25 Oct 2023
CEO and CFO
Buy
2,500
$7.91
$19.78K
Snehal Patel
10 Oct 2023
CEO and CFO
Buy
1,000
$9.07
$9.07K
Snehal Patel
4 Oct 2023
CEO and CFO
Buy
2,000
$8.63
$17.26K
Jaye Thompson
26 Sep 2023
VP Clinical Reg Affairs
Buy
600
$8.71
$5.23K
Snehal Patel
19 Sep 2023
CEO and CFO
Buy
4,000
$8.95
$35.80K
Snehal Patel
11 Sep 2023
CEO and CFO
Buy
1,000
$9.48
$9.48K
Snehal Patel
22 Aug 2023
CEO and CFO
Buy
1,000
$9.97
$9.97K
Snehal Patel
4 Aug 2023
CEO and CFO
Buy
2,000
$10.55
$21.10K
Snehal Patel
21 Jul 2023
CEO and CFO
Buy
1,000
$9.20
$9.20K
Jaye Thompson
13 Jul 2023
VP Clinical Reg Affairs
Buy
250
$9.49
$2.37K
Snehal Patel
17 May 2023
CEO and CFO
Buy
1,000
$11.69
$11.69K
Jaye Thompson
28 Apr 2023
VP Clinical Reg Affairs
Buy
250
$11.22
$2.81K
Snehal Patel
19 Apr 2023
CEO and CFO
Buy
7,000
$11.10
$77.70K
Snehal Patel
18 Apr 2023
CEO and CFO
Buy
2,000
$11.12
$22.24K
Snehal Patel
11 Apr 2023
CEO and CFO
Buy
5,000
$12.42
$62.10K
Jaye Thompson
11 Apr 2023
VP Clinical Reg Affairs
Buy
1,000
$11.87
$11.87K
Jaye Thompson
15 Mar 2023
VP Clinical Reg Affairs
Buy
250
$12.71
$3.18K
Snehal Patel
10 Mar 2023
CEO and CFO
Buy
1,000
$12.12
$12.12K
Jaye Thompson
24 Feb 2023
VP Clinical Reg Affairs
Buy
250
$15.40
$3.85K
Snehal Patel
17 Feb 2023
CEO and CFO
Buy
600
$16.53
$9.92K
Snehal Patel
10 Feb 2023
CEO and CFO
Buy
1,000
$18.68
$18.68K
Jaye Thompson
3 Feb 2023
VP Clinical Reg Affairs
Buy
250
$20.84
$5.21K
Jaye Thompson
27 Jan 2023
VP Clinical Reg Affairs
Buy
250
$19.20
$4.80K
Snehal Patel
27 Jan 2023
CEO and CFO
Buy
2,000
$19.35
$38.70K
Snehal Patel
20 Jan 2023
CEO and CFO
Buy
1,500
$17.37
$26.06K
Jaye Thompson
13 Jan 2023
VP Clinical Reg Affairs
Buy
250
$16.50
$4.13K
Snehal Patel
6 Jan 2023
CEO and CFO
Buy
1,500
$15.18
$22.77K
Snehal Patel
29 Dec 2022
CEO and CFO
Buy
4,000
$15.19
$60.76K
Jaye Thompson
16 Dec 2022
VP Clinical Reg Affairs
Buy
250
$12.94
$3.24K
Snehal Patel
16 Dec 2022
CEO and CFO
Buy
1,000
$13.01
$13.01K
Snehal Patel
9 Dec 2022
CEO and CFO
Buy
2,000
$13.11
$26.22K
Jaye Thompson
2 Dec 2022
VP Clinical Reg Affairs
Buy
250
$13.98
$3.50K
Snehal Patel
2 Dec 2022
CEO and CFO
Buy
1,000
$13.84
$13.84K
Snehal Patel
2 Nov 2022
CEO and CFO
Buy
2,000
$8.79
$17.58K
Snehal Patel
14 Oct 2022
CEO and CFO
Buy
3,000
$9.75
$29.25K
Snehal Patel
7 Oct 2022
CEO and CFO
Buy
2,000
$9.72
$19.44K
Snehal Patel
30 Sep 2022
CEO and CFO
Buy
1,000
$9.46
$9.46K
Snehal Patel
29 Sep 2022
CEO and CFO
Buy
1,000
$9.23
$9.23K
Snehal Patel
24 Jun 2022
CEO and CFO
Buy indirect
6,465
$9.13
$59.03K
Snehal Patel
24 Jun 2022
CEO and CFO
Buy
22,535
$9.13
$205.74K
Snehal Patel
16 Jun 2022
CEO and CFO
Buy
8,000
$7.13
$57.04K
Snehal Patel
14 Jun 2022
CEO and CFO
Buy
12,000
$7.91
$94.92K
Snehal Patel
10 Jun 2022
CEO and CFO
Buy
12,000
$8.33
$99.96K
Snehal Patel
9 Jun 2022
CEO and CFO
Buy
4,500
$10.90
$49.05K
Snehal Patel
7 Jun 2022
CEO and CFO
Buy
6,000
$8.55
$51.30K
Snehal Patel
3 Jun 2022
CEO and CFO
Buy
9,250
$8.35
$77.24K
Snehal Patel
2 Jun 2022
CEO and CFO
Buy
6,774
$7.38
$49.99K
Frank Joseph Daugherty
25 Apr 2022
Chief Medical Officer
Buy
1,000
$16.25
$16.25K
Snehal Patel
21 Apr 2022
CEO and CFO
Buy
6,000
$16.09
$96.54K
Jaye Thompson
19 Apr 2022
VP Clinical Reg Affairs
Buy
500
$16.74
$8.37K
Snehal Patel
19 Apr 2022
CEO and CFO
Buy
6,000
$16.74
$100.44K
Snehal Patel
11 Feb 2022
CEO and CFO
Buy
5,500
$19.80
$108.90K
Snehal Patel
4 Feb 2022
CEO and CFO
Buy
5,000
$19.59
$97.95K
Jaye Thompson
31 Jan 2022
VP Clinical Reg Affairs
Buy
500
$18.47
$9.24K
Kenneth Hallock
21 Jan 2022
Director
Buy
300
$16.32
$4.90K
Jaye Thompson
21 Jan 2022
VP Clinical Reg Affairs
Buy
500
$16.33
$8.17K
Jaye Thompson
18 Jan 2022
VP Clinical Reg. Affairs
Buy
500
$18.87
$9.44K
Frank Joseph Daugherty
13 Jan 2022
Chief Medical Officer
Buy
1,000
$19.99
$19.99K
Jaye Thompson
13 Jan 2022
VP Clinical Reg. Affairs
Buy
1,000
$19.99
$19.99K
Snehal Patel
13 Jan 2022
CEO and CFO
Buy
1,000
$19.99
$19.99K
Snehal Patel
3 Jan 2022
CEO and CFO
Buy
2,050
$23.82
$48.83K
David McWilliams
14 Dec 2021
Director
Buy
200
$27.56
$5.51K
Frank Joseph Daugherty
14 Dec 2021
Chief Medical Officer
Buy
1,111
$26.99
$29.98K
Snehal Patel
14 Dec 2021
CEO and CFO
Buy
1,840
$27.17
$49.99K
Snehal Patel
13 Apr 2021
CEO and CFO
Buy
2,700
$36.98
$99.85K
Kenneth Hallock
24 Nov 2020
Director
Buy indirect
1,000
$5.39
$5.39K
Frank Joseph Daugherty
23 Nov 2020
Chief Medical Officer
Buy
1,000
$5.10
$5.10K
Eric Rothe
20 Nov 2020
Director
Buy
2,000
$5.40
$10.80K
Kenneth Hallock
20 Nov 2020
Director
Buy indirect
1,000
$5.37
$5.37K
David McWilliams
20 Nov 2020
Director
Buy
1,500
$5.40
$8.10K
Snehal Patel
19 Nov 2020
CEO and CFO
Buy
2,000
$5.40
$10.80K
David McWilliams
29 Sep 2020
Director
Buy
2,608
$5.75
$15.00K
Frank Joseph Daugherty
29 Sep 2020
Chief Medical Officer
Buy
1,739
$5.75
$10.00K
Snehal Patel
29 Sep 2020
CEO and CFO
Buy
114,347
$5.75
$657.50K
Kenneth Hallock
29 Sep 2020
Director
Buy indirect
74,782
$5.75
$430.00K
Kenneth Hallock
29 Sep 2020
Director
Buy indirect
8,333
$4.60
$38.35K
Snehal Patel
29 Sep 2020
CEO and CFO
Buy
16,667
$4.60
$76.71K

What was left out

Form 4 filings counted 135
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,644,519
History held since 29 Sep 2020